Inquis Medical, a pioneering medical technology company specializing in advanced thrombectomy systems, today announced the successful closure of its $40 million Series B financing round. This ...

PORTAGE, Mich., March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.

PORTAGE, Mich., July 29, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy ...

The MarketWatch News Department was not involved in the creation of this content. Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

PE or PEERLESS, the choice of therapy was shifting, influenced by patient factors and institutional protocols.

The COGNITIVE Study is a prospective, global, multi-center, single-arm study that evaluates the cognitive preservation made possible by TIGERTRIEVER’s active technology. SOUTHLAKE, Texas--(BUSINESS ...

Results of AVENTUS IDE Trial presented at SCAI Scientific Sessions MENLO PARK, Calif. and WASHINGTON, May 02, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic ...

IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ...

New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

• The incidence of no-reflow was significantly higher in the thrombectomy group (1.4% vs 0.2%), which researchers attributed ...